Gene: BDNF-AS ×
Source: BEFREE ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. 24329127

2014
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease. 24394906

2014
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease. 24394906

2014
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. 24329127

2014
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease. 24394906

2014
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. 24329127

2014
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE In conclusion, there is no enough evidence for associations between BDNF polymorphisms (G196A and C270T) and PD risk at present. 23611539

2013
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease. 24051673

2013
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE In conclusion, there is no enough evidence for associations between BDNF polymorphisms (G196A and C270T) and PD risk at present. 23611539

2013
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease. 24051673

2013
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease. 24051673

2013
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE In conclusion, there is no enough evidence for associations between BDNF polymorphisms (G196A and C270T) and PD risk at present. 23611539

2013
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE LRRK2 p.G2385R variant (odds ratio [OR] = 3.2; 95% confidence interval [CI] = 1.96-5.15, p < 0.0001), not BDNF p.V66M alone significantly increased the risk of PD. 21924942

2012
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE LRRK2 p.G2385R variant (odds ratio [OR] = 3.2; 95% confidence interval [CI] = 1.96-5.15, p < 0.0001), not BDNF p.V66M alone significantly increased the risk of PD. 21924942

2012
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease. 21167764

2011
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE Thus, we determined the distribution of BDNF Val66Met polymorphism in 184 Greek patients with sporadic PD and 113 control participants using polymerase chain reaction-restriction fragment length polymorphism, and explored the association of the polymorphism with certain clinical parameters of the disease. 22001244

2011
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE Thus, we determined the distribution of BDNF Val66Met polymorphism in 184 Greek patients with sporadic PD and 113 control participants using polymerase chain reaction-restriction fragment length polymorphism, and explored the association of the polymorphism with certain clinical parameters of the disease. 22001244

2011
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease. 21167764

2011
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE G196A polymorphism is not a risk factor for PD and does not seem to modify clinical features in PD patients studied here. 20085561

2010
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE G196A polymorphism is not a risk factor for PD and does not seem to modify clinical features in PD patients studied here. 20085561

2010
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE G196A polymorphism is not a risk factor for PD and does not seem to modify clinical features in PD patients studied here. 20085561

2010
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. 18977816

2009
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease. 19538209

2009
dbSNP: rs746682028
rs746682028
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE A possible association between Parkinson's disease (PD) and the polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies that nevertheless yielded-contrasting result. 19538209

2009
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.100 GeneticVariation BEFREE BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. 18977816

2009